Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)
Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed) has been closed on 14 Sep 2022.
It no longer accepts any bids. For further information,
you can contact the National Institutes of Health
Bellow, you can find more information about this project:
The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications focused on advancing development of vaccine candidates against Enterotoxigenic Escherichia coli (ETEC), Salmonella enterica serotype Paratyphi A, and two Shigella species, Shigella flexneri and S. sonnei.